PGNY Multiplikator forward rega marang pendapatan Progyny

Progyny Corp (PGNY) - logo korporat

Progyny, Inc. (PGNY) demonstrates a superior level of management and transparency in its dealings with Fortune 500 clients. The expected P/S valuation confirms market dynamics, with the metric holding around 1.60. Social responsibility and the digitalization of processes support the company's ESG status, while strict adherence to environmental standards minimizes its operational footprint within the reproductive health sector.

PGNY Progyny Inc: Kapitalisasi marang prakiraan pendapatan ing interval 04.07.2022 - 17.11.2026

Rincian metrik komprehensif lan analitis Progyny, Inc. (PGNY)

- rega saiki lan proyeksi nilai saham:
Analisis komprehensif perusahaan:PGNY (Progyny, Inc.)
Produk sing diprodhuksi Progyny Corp

The margin of safety for Progyny, Inc. (PGNY) is determined by the ratio of market capitalization to projected sales. Operating exclusively in the US minimizes geopolitical risks, tying the business value to US corporate budgets. According to this forward price-to-sales chart, the current value of 1.60 reflects the cost per unit of future revenue. This indicator allows for the classification of the asset based on its degree of overbought status relative to the expected revenue growth rate.

Analisis pesaing Progyny, Inc.

Multiplikator Forward P/S HCA (HCA Healthcare, Inc.)|Rasio rega marang pendapatan sing dikarepake THC (Tenet Healthcare)|FMS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep solventum.com|EHC: Multiplikator Forward P/S|UHS - Rasio kapitalisasi marang dodolan sing dikarepake|DVA (DaVita Corp) - Multiplikator Forward P/S|RDNT: Rega forward marang dodolan|Multiplikator Forward P/S OPCH|SGRY (surgerypartners.com) - Rega forward marang dodolan|Multiplikator Forward P/S PINC (Premier Inc)|National Vision - Rasio rega marang prakiraan pendapatan|Ardent Health - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Select Medical Corp SEM|ASTH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan MD|USPH (US Physical Therapy Inc) - Multiplikator Forward P/S|PNTG: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Rega forward marang dodolan|Multiplikator Forward P/S AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|EOLS - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan MDWD|Rasio rega marang prakiraan pendapatan biote Corp.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep thejoint.com JYNT|Multiplikator Forward P/S DCGO|Multiplikator forward rega marang pendapatan P3 Health PIII|Multiplikator Forward P/S GANX (Gain Therapeutics Inc.)|Multiplikator Forward P/S EUDA Health Holdings Limited EUDA|baselmedical.com - Multiplikator Forward P/S|CLGN: Rasio rega marang prakiraan pendapatan|Cuprina Holdings (Cayman) Ltd. (CUPR) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Concord Medical|AMS (American Shared Hospital Services Inc) - Multiplikator Forward P/S|MEDIROM Corp (MRM) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S ALBT|Rasio kapitalisasi marang dodolan sing dikarepake DIH Holding|Multiplikator Forward P/S XAGE (carmellcosmetics.com)|NIVF: Kapitalisasi marang prakiraan pendapatan|ATIP: Multiplikator forward rega marang pendapatan|CareMax Medical Group - Rasio rega marang pendapatan sing dikarepake|Kindly MD (KDLY) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan MODV|Rasio rega marang prakiraan pendapatan Novo Integrated Sciences Corp|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep SunLink Health Systems SSY|Rasio rega marang prakiraan pendapatan IMAC Corp (BACK)